Cure for genetic diseases a step closer

Image
IANS New York
Last Updated : Jul 16 2015 | 3:13 PM IST

Scientist have developed a method to turn cells from patients into mutation-free stem cells that can treat genetic diseases for which there is currently no cure.

"Right now, there are no cures for mitochondrial diseases," said senior author Juan Carlos Izpisua Belmonte, professor at Salk Institute for Biological Studies in California, US.

Mitochondrial diseases are caused by any of 200 mutations that affect the genes of mitochondria, tiny powerhouses inside nearly every cell of the body.

Depending on the affected genes and cell types, the diseases can cause muscle weakness, liver disease, diabetes, seizures, developmental delays or vision problems.

Existing therapies aim to ease the symptoms or slow the progression of the diseases, but cannot entirely cure them.

"We have developed ways to prevent these diseases, so it was natural to next ask how we could treat them," Belmonte said.

The researchers collected skin samples from patients with mitochondrial encephalomyopathy or Leigh Syndrome, both severe disorders that affect the brain and muscles.

In the study published in the journal Nature, the researchers described a method to generate stem cells even from patients who do not have cells with enough -- or any -- healthy mitochondria to start with.

For now, the researchers can use the healthy cells to generate heart, brain, muscle or eye cells from the mutation-free stem cells.

But methods to make those cells fully mature and functional and transplant them into patients are still under development, the study said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 16 2015 | 3:02 PM IST

Next Story